Odimma Therapeutics Secures €2M in Seed Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Touchlight Genetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Touchlight Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Touchlight Genetics Today - Breaking & Trending Today
Odimma Therapeutics Secures €2 Million to Complete the Preparation of Its First-in-Man Clinical Trial
Odimma Therapeutics, a biotechnology company specialized in personalized cancer immunotherapy announces a seed fundraising of €2 million in order to secure the preparation on its First-in-Man clinical
Source: finanznachrichten.de
TAAV Names Biomanufacturing Innovator Dolores Baksh Chief Executive Officer
/PRNewswire/ -- TAAV Biomanufacturing Solutions, S.L. (TAAV), an independently operated wholly-owned subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio),...
Source: prnewswire.com
First approval of TAAV synthetic DNA material for use in clinical trial
Synthetic DNA material to be used in upcoming approved Huntington's disease study in France may be key to scaling gene therapy production
Source: adnkronos.com
Synthetic Biology: The $3.6 Trillion Science Changing Life As We Know It
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Source: zerohedge.com